Monuril (Fosfomycin Trometamol)

Fosfomycin trometamol blocks the MurA enzyme, which is essential for the first step of bacterial cell‑wall peptidoglycan synthesis. By inactivating this enzyme, the drug prevents the formation of a functional cell wall, leading to bacterial lysis and death.

The prescribed dose of Monuril is determined by the treating clinician based on the patient’s condition, renal function, and local prescribing guidelines. The medication is supplied as a single‑dose oral powder that is reconstituted for ingestion.

The safety of fosfomycin trometamol in pregnancy and lactation has not been fully established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To request Monuril, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Monuril offers a single‑dose oral regimen, which can improve adherence compared with multi‑day courses of other antibiotics such as trimethoprim‑sulfamethoxazole or nitrofurantoin. Its unique mechanism targeting MurA provides activity against many resistant strains, though susceptibility testing remains essential.

Monuril should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture. Keep the product away from direct sunlight and excessive heat to maintain stability.

Monuril is supplied as a dry oral powder that is reconstituted with a specified amount of water to form a solution. The patient drinks the solution after it has been mixed, typically on an empty stomach to optimise absorption.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, Clostridioides difficile‑associated colitis, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience rash, swelling, difficulty breathing, or persistent gastrointestinal symptoms.

Monuril should not be used by individuals with a known hypersensitivity to fosfomycin or any of its excipients. Caution is advised in patients with severe renal impairment, and it is generally avoided in pregnant women unless the benefits outweigh the risks.